What is administered to Rh-negative mothers before the amniocentesis procedure?

What is administered to Rh-negative mothers before the amniocentesis procedure?

• A. Folic acid
• B. Iron supplements
• C. Rh immunoglobulin
• D. Vitamin K

Answer: (C)

Rh immunoglobulin is administered to Rh-negative mothers before the amniocentesis procedure to prevent Rh sensitization. In cases where an Rh-negative mother is pregnant with an Rh-positive fetus, there is a risk that the mother’s immune system might produce antibodies against the Rh-positive blood cells, particularly if fetal blood cells enter the maternal circulation during procedures like amniocentesis. This can lead to hemolytic disease of the newborn in future pregnancies if the mother becomes sensitized. By giving Rh immunoglobulin, the mother’s immune system is prevented from recognizing the Rh-positive blood cells as foreign entities, thus protecting the fetus and future pregnancies from potential complications associated with Rh incompatibility. Other options, while important in their own contexts, do not address the specific need related to Rh incompatibility and the risks associated with invasive procedures like amniocentesis. Folic acid is important for fetal development, iron supplements address anemia, and vitamin K is used for clotting issues, but none of these mitigate the risk of Rh sensitization related to the procedure.

Rh immunoglobulin is administered to Rh-negative mothers before the amniocentesis procedure to prevent Rh sensitization. In cases where an Rh-negative mother is pregnant with an Rh-positive fetus, there is a risk that the mother’s immune system might produce antibodies against the Rh-positive blood cells, particularly if fetal blood cells enter the maternal circulation during procedures like amniocentesis. This can lead to hemolytic disease of the newborn in future pregnancies if the mother becomes sensitized. By giving Rh immunoglobulin, the mother’s immune system is prevented from recognizing the Rh-positive blood cells as foreign entities, thus protecting the fetus and future pregnancies from potential complications associated with Rh incompatibility.

Other options, while important in their own contexts, do not address the specific need related to Rh incompatibility and the risks associated with invasive procedures like amniocentesis. Folic acid is important for fetal development, iron supplements address anemia, and vitamin K is used for clotting issues, but none of these mitigate the risk of Rh sensitization related to the procedure.